William Blair & Company’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-8,473
Closed -$255K 1872
2024
Q1
$255K Sell
8,473
-31,882
-79% -$885K ﹤0.01% 1314
2023
Q4
$1.15M Sell
40,355
-3,571
-8% -$105K ﹤0.01% 813
2023
Q3
$1.63M Sell
43,926
-4,325
-9% -$165K 0.01% 713
2023
Q2
$1.88M Sell
48,251
-50
-0.1% -$1.96K 0.01% 680
2023
Q1
$1.76M Sell
48,301
-14,499
-23% -$458K 0.01% 687
2022
Q4
$1.93M Buy
+62,800
New +$1.95M 0.01% 642

Other funds holding RTO

William Blair & Company's RTO Position: Q2 2024 in Review

William Blair & Company sold out of Rentokil (RTO) in Q2 2024, closing a stake of 8,473 shares — an estimated $255K sold.

William Blair & Company first reported a position in RTO in Q4 2022 and held it in 6 quarters. The position peaked at $1.93M in Q4 2022. 232 funds tracked by Wall St. Rank hold RTO as of Q2 2024.

  • William Blair & Company reported no remaining Rentokil position as of Q2 2024 after selling out during the quarter.
  • William Blair & Company sold 8,473 Rentokil shares in Q2 2024, an estimated $255K.
  • William Blair & Company first reported a position in Rentokil in Q4 2022 and held it in 6 quarters.
  • William Blair & Company's Rentokil position peaked at $1.93M in Q4 2022.
  • 232 funds tracked by Wall St. Rank held Rentokil as of Q2 2024.

Based on William Blair & Company's 13F filing for Q2 2024, filed 12 Aug 2024.